Add BrightSurf on Google Email

Low-dose anticoagulation therapy can be used safely with new design mechanical heart valve

A new study published in The Journal of Thoracic and Cardiovascular Surgery found that low-dose anticoagulation therapy can be safely used with a newer generation mechanical heart valve. Patients under 65 years old who received this valve had significantly lower risk of bleeding without an increased incidence of thromboembolism.

SourceAmerican Association for Thoracic Surgery·JournalJournal of Thoracic and Cardiovascular Surgery·DateMay 15, 2014

Too much prolonged high-intensity exercise risks heart health

Two studies indicate that more intense exercise does not always mean better for heart health. Overdosing on high-intensity exercise may actually increase the risk of death from a heart attack or stroke in those with existing heart disease. Moderate exercise at moderate intensity is key to maximizing cardiovascular benefits.

SourceBMJ Group·JournalHeart·DateMay 14, 2014

Societies publish recommendations to guide minimally invasive valve therapy programs for patients

The document outlines criteria for healthcare providers and institutions to offer consistent and appropriate care to patients in transcatheter valve therapy. A multi-disciplinary team approach is emphasized, involving both surgeons and interventional cardiologists, to improve patient treatment and outcomes.

SourceAmerican College of Cardiology·JournalCatheterization and Cardiovascular Interventions·DateMay 14, 2014

Boring cells could hold the key to heart disease

Researchers found that cardiac fibroblasts are unique cells with organ-specific functions and can be used in replacement therapies for congenital heart disease and heart failure. They have specific genes that tell them to become heart cells, making them a promising alternative to heart transplants.

SourceMonash University·JournalCirculation Research·DateApr 24, 2014

Genetic cause of heart valve defects

Scientists at the University of Bonn identified Creld1 as a crucial gene for heart valve development in mice, which also functions similarly in humans. This discovery may lead to improved diagnosis of unidentified heart valve diseases and better understanding of cardiac development.

SourceUniversity of Bonn·JournalDevelopmental Cell·DateMar 31, 2014

Waiting for a donor heart: Motion prolongs survival

A new study found that patients with advanced cardiac insufficiency who remain active and have low levels of depression can significantly increase their chances of surviving the waiting period for a donor heart. The researchers recommend psychological counseling to help patients stay physically active and reduce symptoms of depression.

SourceUniversity of Luxembourg·JournalHealth Psychology·DateMar 6, 2014

Heart failure unknowns a roadblock to managing health

A systematic review of 49 studies found that patients with heart failure and their families often lack basic knowledge about the condition, leading to confusion, delays in seeking help, and uncertainty about long-term care. This lack of understanding can decimate quality of life and is a major reason seniors end up in emergency rooms.

SourceUniversity of Alberta·JournalHeart·DateMar 5, 2014

Immune cells may heal an injured heart

A study in mice reveals two major pools of immune cells that promote healing and drive inflammation in the heart. Healthy hearts maintain a population of embryonic macrophages, while adult macrophages are recruited during cardiac stress, leading to inflammation. The findings provide new insights into the complex interplay between these...

SourceWashU Medicine·JournalImmunity·DateJan 16, 2014